Work

PCSK9 inhibition in the management of familial hypercholesterolemia

Year: 2017

Type: article

Source: Journal of Cardiology

DOI: 10.1016/j.jjcc.2017.07.002

Author: Masatsune Ogura

Institutions: National Cerebral and Cardiovascular Center, National Cerebral and Cardiovascular Center Research Institute

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Amgen, Astellas Pharma, Japan Society for the Promotion of Science

Awards: Is HDL quality a good candidate for novel therapeutic target of cardiovascular disease?, Residual risk control in familial hypercholesterolemia: Identification of lipids responsible for HDL malignant transformation

OpenAlex ID: W2744116768

FWCI: 5.62

Cites: 26

Cited by: 88

Related to: 10